Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: Pharmacol Biochem Behav. 2007 Feb 20;86(4):667–677. doi: 10.1016/j.pbb.2007.02.012

Fig. 4.

Fig. 4

VAS ratings of “Sick”, “Bad” and “Dizzy” after IV administration of 5 or 10 mg/kg nalbuphine. Significant changes from baseline are indicated by asterisks (*, P < 0.05). Times when VAS ratings differed between subjects who received 5 or 10 mg nalbuphine are indicated by daggers (†, P <0.05).